Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lofexidine for Inpatient Opiate Detoxification
NCT00235729Phase 3Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Jun 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in opioid withdrawal syndrome (OWS) comparing Lofexidine with Placebo (2 arms). Primary endpoints: Short Opiate Withdrawal Scale (Gossop) at Day 3 and Time to dropout during treatment phase. Started Jun 2006; status: completed.
02
Drugs
lofexidine
03
Conditions
opioid withdrawal syndrome (OWS)
Beyond the preview
Go deeper on NCT00235729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00235729.